Award recordCONTRACT

OPTUM PHARMACY 801, INC.

PIID 36C26026D0003· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· Q517 · PHARMACY SERVICES· FY2026· $0 net obligations· UEI K5MHR9JB9ND5· AZ

Description

IMPLEMENTING EO 14398 DEI DISCRIMINATION

Base award description: PHARMACY HAZARDOUS COMPOUNDING SERVICES

First action · last action
2025-10-01 · 2026-06-12
Transactions
3
First transaction's obligation
$0
Base + all options value (sum of deltas)
$20,000
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2025-10-01 · this action $0 · running total $0Modification P00001 · 2025-12-01 · this action $0 · running total $0Modification A14398 · 2026-06-12 · this action $0 · running total $0
  • Base2025-10-01+$0= $0
  • Mod P000012025-12-01+$0= $0
  • Mod A143982026-06-12+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2025-10-01+$0$0PHARMACY HAZARDOUS COMPOUNDING SERVICES
Mod P00001· ENTITY ADDRESS CHANGE2025-12-01+$0$0PHARMACY HAZARDOUS COMPOUNDING SERVICES
Mod A14398· OTHER ADMINISTRATIVE ACTION2026-06-12+$0$0IMPLEMENTING EO 14398 DEI DISCRIMINATION

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI K5MHR9JB9ND5)

AwardOffice · PSC / listingNet obligationsFY
36C25526N0168255-NETWORK CONTRACT OFFICE 15 (36C255) · Q517 · PHARMACY SERVICES$0FY2026
36C26126P0374261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$156,000FY2026
36C24226N0311242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$200,000FY2026
36C24226N0309242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$269,557FY2026
36C26026N0063260-NETWORK CONTRACT OFFICE 20 (36C260) · Q517 · PHARMACY SERVICES$557FY2026
36C24226N0127242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$20,584FY2026

Other recipients under Q517 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026P0655EUROFINS DISCOVERX PRODUCTS, LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$6,845FY2026
36C26026N0259KELLEY-ROSS & ASSOC., INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$4,916FY2026
36C26026D0035KELLEY-ROSS & ASSOC., INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$0FY2026
36C26026P0006B. BRAUN MEDICAL INC260-NETWORK CONTRACT OFFICE 20 (36C260)$5,700FY2026
36C26025N0310PALISADE-HERITAGE JV LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$220,000FY2025

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36C26026D0003_3600 · retrieved 2026-09-26.